For instance, multi-biomarker panels, such as GALAD (gender, age, alpha-fetoprotein L3%, AFP, and des-gamma-carboxy prothrombin) scores, show very good performance, with 80% sensitivity for early HCC [86]. The gene discussed is AFP; the disease is hepatocellular carcinoma.